Study provides new insight on rotavirus

12/25/2008 | EurekAlert!

Australian researchers found that a strain of the rotavirus previously thought unresponsive to sialidase, a standard protein therapy, actually recognized and attached to a type of sialic acid that is "not accessible" to the treatment. The researchers explored the interaction between the virus and its host cells with the aid of nuclear magnetic resonance spectroscopy, 3-D modeling and cell-based assays.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park